These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1088 related items for PubMed ID: 16015534

  • 21. Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors.
    Blackledge G, Averbuch S.
    Br J Cancer; 2004 Feb 09; 90(3):566-72. PubMed ID: 14760365
    [Abstract] [Full Text] [Related]

  • 22. Role of tyrosine kinase inhibitors in lung cancer.
    Ansari J, Palmer DH, Rea DW, Hussain SA.
    Anticancer Agents Med Chem; 2009 Jun 09; 9(5):569-75. PubMed ID: 19519298
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor receptor inhibition strategies in oncology.
    Harari PM.
    Endocr Relat Cancer; 2004 Dec 09; 11(4):689-708. PubMed ID: 15613446
    [Abstract] [Full Text] [Related]

  • 24. Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
    Ramalingam S, Forster J, Naret C, Evans T, Sulecki M, Lu H, Teegarden P, Weber MR, Belani CP.
    J Thorac Oncol; 2008 Mar 09; 3(3):258-64. PubMed ID: 18317068
    [Abstract] [Full Text] [Related]

  • 25. Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population.
    Wheler J, Falchook G, Tsimberidou AM, Hong D, Naing A, Piha-Paul S, Chen SS, Heymach J, Fu S, Stephen B, Fok JY, Janku F, Kurzrock R.
    Oncotarget; 2013 May 09; 4(5):772-84. PubMed ID: 23800712
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.
    Lung Cancer; 2011 Feb 09; 71(2):166-72. PubMed ID: 20541833
    [Abstract] [Full Text] [Related]

  • 32. [Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?].
    Grenier J, Soria JC.
    Bull Cancer; 2007 Jan 09; 94(1):53-61. PubMed ID: 17237005
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
    Chung CH, Seeley EH, Roder H, Grigorieva J, Tsypin M, Roder J, Burtness BA, Argiris A, Forastiere AA, Gilbert J, Murphy B, Caprioli RM, Carbone DP, Cohen EE.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 09; 19(2):358-65. PubMed ID: 20086114
    [Abstract] [Full Text] [Related]

  • 36. Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
    Lim SH, Lee JY, Sun JM, Ahn JS, Park K, Ahn MJ.
    J Thorac Oncol; 2014 Apr 09; 9(4):506-11. PubMed ID: 24736073
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.
    Murphy M, Stordal B.
    Drug Resist Updat; 2011 Jun 09; 14(3):177-90. PubMed ID: 21435938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.